Search Results - Bernadette de Rauglaudre

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Neoadjuvant radiotherapy combined with fluorouracil-cisplatin plus cetuximab in operable, locally advanced esophageal carcinoma: Results of a phase I-II trial (FFCD-0505/PRODIGE-3)

    Neoadjuvant radiotherapy combined with fluorouracil-cisplatin plus cetuximab in operable, locally advanced esophageal carcinoma: Results of a phase I-II trial (FFCD-0505/PRODIGE-3) by Bernadette de Rauglaudre, Guillaume Piessen, Marine Jary, Karine Le Malicot, Antoine Adenis, Thibault Mazard, Xavier Benoît D’Journo, Caroline Petorin, Joelle Buffet-Miny, Thomas Aparicio, Rosine Guimbaud, Véronique Vendrely, Côme Lepage, Laetitia Dahan

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Predictive value of vascular endothelial growth factor polymorphisms for maintenance bevacizumab efficacy in metastatic colorectal cancer: an ancillary study of the PRODIGE 9 phase III trial

    Predictive value of vascular endothelial growth factor polymorphisms for maintenance bevacizumab efficacy in metastatic colorectal cancer: an ancillary study of the PRODIGE 9 phase... by Bernadette de Rauglaudre, Camille Sibertin-Blanc, Aurélie Fabre, Karine Le Malicot, Jaafar Bennouna, François Ghiringhelli, Julien Taïeb, Valérie Boige, Olivier Bouché, Thierry Chatellier, Roger Faroux, Eric François, Stéphane Jacquot, Dominique Genet, Claire Mulot, Sylviane Olschwang, Jean-François Seitz, Thomas Aparicio, Laetitia Dahan

    Published 2022-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: